SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL)
IMCL 0.1590.0%Oct 5 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. Seuss who wrote (883)7/13/1999 4:35:00 PM
From: cirrus  Read Replies (1) of 2515
 
When products come to market the rate of price appreciation may well slow as IMCL will be valued like other companies - stuff like PE ratios, quarterly earnings, competitors products and the like will become more important. However, IMCL may well be trading at $150 then. Now is the golden age - a pure play on a future that appears extraordinarily promising. Enjoy the ride and hope the trials do not disclose anything that might cause the FDA to delay approval.

>>>anyone care to venture what will happen if/when these drugs come on line?<<<
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext